AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Frances Oldham Kelsey MD, PhD, has earned her place as “America’s Greatest Living Heroine” — she turned 100 on July 24, 2014. Dr. Kelsey was the medical pharmacologist at the FDA who refused to license thalidomide for the U.S. market despite the enormous pressures put upon her by a pharmaceutical…
NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, 2 Jun 2004 The New York Times saw fit to print a report about preliminary, unpublished findings of a study whose authors claim to have “found that Prozac helps teenagers overcome depression far…
War hero’s death in clinical trial follows years of FDA neglect – Bloomberg News Thu, 10 Nov 2005 Bloomberg News reports that a decorated veteran of the Vietnam war was killed in 2002, in a clinical drug trial at the FABRE Research Clinic in Houston, Texas. The FDA had found…
Children and antidepressants – CNN Financial Today Fri, 12 Nov 2004 When CNN was looking for an expert with a responsible, balanced view about the concerns of prescribing psychotropic drugs for children, they turned to AHRP. We recommended psychiatrist, Dr. Joseph Glenmullen, a practicing clinician and Harvard faculty member, whose…
Lilly duloxetine drug trial–19 Quit after a suicide – Philadelphia Inquirer Fri, 13 Feb 2004 19-year old Teri Johnson’s suicide occurred one week after an FDA advisory committee had urged the FDA to issue warnings about prescribing antidepressant drugs for children under 18 because of an increased risk in suicide….
Suicide in Psych Drug Trials: FDA Orwelian doublespeak – Insight Magazine Date: Mon, 14 Oct 2002 Insight Magazine’s interview with Dr. Thomas Laughren, team leader for the neuropharmachological drug-products division of the FDA, shows that FDA was caught off guard when Dr. Arif Khan independently analyzed FDA’s data revealing that…
